메뉴 건너뛰기




Volumn 288, Issue 4, 2013, Pages 901-904

Initiation of ovarian stimulation independent of the menstrual cycle: A case-control study

Author keywords

Fertility preservation; GnRH antagonist; In vitro fertilization; Luteal phase; Ovarian stimulation

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADORELIN ANTAGONIST; GONADOTROPIN; PROGESTERONE; UROFOLLITROPIN;

EID: 84885337249     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-013-2794-z     Document Type: Article
Times cited : (39)

References (12)
  • 1
    • 0028283353 scopus 로고
    • Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation
    • 7929723 1:STN:280:DyaK2M%2FhsVyqtw%3D%3D (Oxford, England)
    • Diedrich K, Diedrich C, Santos E, Zoll C, al-Hasani S, Reissmann T et al (1994) Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum Reprod 9:788-791 (Oxford, England)
    • (1994) Hum Reprod , vol.9 , pp. 788-791
    • Diedrich, K.1    Diedrich, C.2    Santos, E.3    Zoll, C.4    Al-Hasani, S.5    Reissmann, T.6
  • 2
    • 78049301586 scopus 로고    scopus 로고
    • Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: An updated meta-analysis
    • 20537631 10.1016/j.fertnstert.2010.04.025 1:CAS:528:DC%2BC3cXhtlent7nK
    • Griesinger G, Kolibianakis EM, Venetis C, Diedrich K, Tarlatzis B (2010) Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis. Fertil Steril 94:2382-2384
    • (2010) Fertil Steril , vol.94 , pp. 2382-2384
    • Griesinger, G.1    Kolibianakis, E.M.2    Venetis, C.3    Diedrich, K.4    Tarlatzis, B.5
  • 3
    • 0037244594 scopus 로고    scopus 로고
    • A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol
    • 12519847 10.1210/jc.2002-020788 1:CAS:528:DC%2BD3sXkvVertA%3D%3D
    • Hohmann FP, Macklon NS, Fauser BC (2003) A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. J Clin Endocrinol Metab 88:166-173
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 166-173
    • Hohmann, F.P.1    Macklon, N.S.2    Fauser, B.C.3
  • 4
    • 79953878958 scopus 로고    scopus 로고
    • Follicular phase endocrine characteristics during ovarian stimulation and GnRH antagonist cotreatment for IVF: RCT comparing recFSH initiated on cycle day 2 or 5
    • 21307142 10.1210/jc.2010-2239 1:CAS:528:DC%2BC3MXltF2qtbs%3D
    • Blockeel C, Sterrenburg MD, Broekmans FJ, Eijkemans MJ, Smitz J, Devroey P et al (2011) Follicular phase endocrine characteristics during ovarian stimulation and GnRH antagonist cotreatment for IVF: RCT comparing recFSH initiated on cycle day 2 or 5. J Clin Endocrinol Metab 96:1122-1128
    • (2011) J Clin Endocrinol Metab , vol.96 , pp. 1122-1128
    • Blockeel, C.1    Sterrenburg, M.D.2    Broekmans, F.J.3    Eijkemans, M.J.4    Smitz, J.5    Devroey, P.6
  • 5
    • 70349446667 scopus 로고    scopus 로고
    • Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase
    • 10.1016/j.fertnstert.2008.08.011
    • von Wolff M, Thaler CJ, Frambach T, Zeeb C, Lawrenz B, Popovici RM et al (2009) Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril 92:1360-1365
    • (2009) Fertil Steril , vol.92 , pp. 1360-1365
    • Von Wolff, M.1    Thaler, C.J.2    Frambach, T.3    Zeeb, C.4    Lawrenz, B.5    Popovici, R.M.6
  • 6
    • 79955020765 scopus 로고    scopus 로고
    • Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles
    • 10.1016/j.fertnstert.2011.01.030 10.1016/j.fertnstert.2011.01.030
    • Sonmezer M, Turkcuoglu I, Coskun U, Oktay K (2011) Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles. Fertil Steril 95(6):2125.e9-2125.e11. doi: 10.1016/j.fertnstert.2011.01.030
    • (2011) Fertil Steril , vol.95 , Issue.6
    • Sonmezer, M.1    Turkcuoglu, I.2    Coskun, U.3    Oktay, K.4
  • 7
    • 24644455926 scopus 로고    scopus 로고
    • Highly efficient vitrification method for cryopreservation of human oocytes
    • 16176668 10.1016/S1472-6483(10)60837-1
    • Kuwayama M, Vajta G, Kato O, Leibo SP (2005) Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online 11:300-308
    • (2005) Reprod Biomed Online , vol.11 , pp. 300-308
    • Kuwayama, M.1    Vajta, G.2    Kato, O.3    Leibo, S.P.4
  • 8
    • 0032827981 scopus 로고    scopus 로고
    • A simple, inexpensive and effective artificial cycle with exogenous transdermal oestradiol and vaginal progesterone for the transfer of cryopreserved pronucleated human oocytes in women with normal cycles
    • 10573036 10.1093/humrep/14.suppl-1.222 1:CAS:528:DyaK1MXnsVSiu78%3D (Oxford, England)
    • Bals-Pratsch M, Al-Hasani S, Schopper B, Diedrich C, Hoepfner AS, Weiss J et al (1999) A simple, inexpensive and effective artificial cycle with exogenous transdermal oestradiol and vaginal progesterone for the transfer of cryopreserved pronucleated human oocytes in women with normal cycles. Hum Reprod 14(Suppl 1):222-230 (Oxford, England)
    • (1999) Hum Reprod , vol.14 , Issue.SUPPL. 1 , pp. 222-230
    • Bals-Pratsch, M.1    Al-Hasani, S.2    Schopper, B.3    Diedrich, C.4    Hoepfner, A.S.5    Weiss, J.6
  • 9
    • 67650325145 scopus 로고    scopus 로고
    • Cryopreservation of human embryos by vitrification or slow freezing: Which one is better?
    • 19276976 10.1097/GCO.0b013e3283297dd6
    • Kolibianakis EM, Venetis CA, Tarlatzis BC (2009) Cryopreservation of human embryos by vitrification or slow freezing: which one is better? Curr Opin Obstet Gynecol 21:270-274
    • (2009) Curr Opin Obstet Gynecol , vol.21 , pp. 270-274
    • Kolibianakis, E.M.1    Venetis, C.A.2    Tarlatzis, B.C.3
  • 10
    • 34347263748 scopus 로고    scopus 로고
    • Molecular mechanisms of ovulation: Co-ordination through the cumulus complex
    • 10.1093/humupd/dml062 1:CAS:528:DC%2BD2sXmtlCisbc%3D
    • Russell DL, Robker RL (2007) Molecular mechanisms of ovulation: co-ordination through the cumulus complex. Hum Reprod Updat 13:289-312
    • (2007) Hum Reprod Updat , vol.13 , pp. 289-312
    • Russell, D.L.1    Robker, R.L.2
  • 11
    • 77952919505 scopus 로고    scopus 로고
    • Ganirelix for luteolysis in poor responder patients undergoing IVF treatment: A Scandinavian multicenter 'extended pilot study'
    • 20504085 10.3109/00016341003721029 1:CAS:528:DC%2BC3cXms1ynsb8%3D
    • Nilsson L, Andersen AN, Lindenberg S, Hausken J, Andersen CY, Kahn JA (2010) Ganirelix for luteolysis in poor responder patients undergoing IVF treatment: a Scandinavian multicenter 'extended pilot study'. Acta Obstet Gynecol Scand 89(6):828-831
    • (2010) Acta Obstet Gynecol Scand , vol.89 , Issue.6 , pp. 828-831
    • Nilsson, L.1    Andersen, A.N.2    Lindenberg, S.3    Hausken, J.4    Andersen, C.Y.5    Kahn, J.A.6
  • 12
    • 22844451495 scopus 로고    scopus 로고
    • Gonadotrophin-releasing hormone-antagonist luteolysis during the preceding mid-luteal phase is a feasible protocol in ovarian hyperstimulation before in vitro fertilization
    • 16026411
    • Fridén BE, Nilsson L (2005) Gonadotrophin-releasing hormone-antagonist luteolysis during the preceding mid-luteal phase is a feasible protocol in ovarian hyperstimulation before in vitro fertilization. Acta Obstet Gynecol Scand 84(8):812-816
    • (2005) Acta Obstet Gynecol Scand , vol.84 , Issue.8 , pp. 812-816
    • Fridén, B.E.1    Nilsson, L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.